January 4, 2022 Research Bulletin
Volume 3, Issue 1
Dear Research Community Colleagues,
As 2021 ended and 2022 began, Boulder County was hit by the Marshall Fire, which has impacted several members in our community. Our condolences to everyone affected by this tragedy. Please reach out and access resources as needed.
COVID continues in 2022. More details will follow later this week regarding our continued research processes in the wake of the omicron variant.
The research community keeps moving with all of your support. We did want to take a moment and share with you the new Chief Research Informatics Office website. Melissa Haendel, PhD and her team are here to support you and your teams as needed. Please email CRIO@cuanschutz.edu for more specifics.
Thanks everyone and please continue to wear masks and follow return to campus guidelines.
Sincerely,
Thomas Flaig, MD
Vice Chancellor for Research
University of Colorado Denver | Anschutz
Featured Funding Opportunities
- 02/02/2022 - NSF Science of Organization
- 02/05/2022 - AHRQ Developing Measures of Shared Decision Making (R01)
- 02/24/2022 - CDC - Understanding Polydrug Use Risk and Protective Factors, Patterns, and Trajectories to Prevent Drug Overdose
- 03/03/2022 - Resources to Promote Coordination and Collaboration across Deeply Phenotyped Longitudinal Behavioral and Social Studies of Aging (U24 Clinical Trial Not Allowed)
- 03/10/2022 - HEAL Initiative: Exploratory Data and Methods to Address Urgent Needs to Stem the Opioid Epidemic (R21- Clinical Trial Not Allowed)
- 03/14/2022 - CDC Rigorous Evaluation of Strategies to Prevent Overdose through Linking People with Illicit Substance Use Disorders to Recovery Support Services
- 03/15/2022 - NIH-DOD-VA Pain Management Collaboratory Pragmatic and/or Implementation Science Demonstration Projects ((UG3/UH3) Clinical Trial Required)
- 03/31/2022 - PBPK Modeling to Support an Assessment of Bioequivalence for Locally-Acting Drugs in the Gastrointestinal Tract (U01) Clinical Trial Optional
- 04/01/2022 - SPARC VNS Endpoints from Standardized Parameters (VESPA) (U54 Clinical Trial Required)
- 04/01/2022 - Research to support the development of alternatives to antimicrobials for use in food-producing animals (U01) Clinical Trial Not Allowed
- 05/18/2022 - Center for Rapid Surveillance of Tobacco (CRST) to Assess Changes in Use Behaviors, Product Marketing, and the Marketplace (U01 Clinical Trial Not Allowed)
- 06/05/2022 - Risk and Protective Factors of Family Health and Family Level Interventions (R01 - Clinical Trial Optional)
NIH Funding Announcements
NIH funding opportunities and notices are presented weekly. Please see the current and past updates below.
Limited Funding Opportunities
Please take a moment to visit and bookmark the newly launched website featuring limited funding opportunities.
To submit a proposal for these opportunities:
Interested candidates must send a one-page summary of their research proposal and their biosketch in pdf format via the Limited Submission Portal.
DoE Energy Frontiers Research Centers
- Materials due to Internal Review Committee: January 11, 2022
- Sponsor Deadline: February 15, 2022
NSF Innovations in Graduate Education (IGE)
- Materials due to Internal Review Committee: January 24, 2022
- Sponsor Deadline: March 22, 2022
DHHS Materials Asthma and Allergic Diseases Cooperative Research Centers
- Materials due to Internal Review Committee: April 12, 2022
- Sponsor Deadline: June 3, 2022
NSF CyberCorps(R) Scholarship for Service (SFS)
- Materials due to Internal Review Committee: May 17, 2022
- Sponsor Deadline: July 15, 2022
NIGMS Bridges to the Doctorate Research Training Program
- Materials due to Internal Review Committee: July 21, 2022
- Sponsor Deadline: September 27, 2022
Special Announcements
American Cancer Society - Institutional Research Grant (ACS-IRG) Seed Grant Funding - 2022
The purpose of this grant program is to support the development of exceptional research projects that will help lead to the conquest of cancer and will further the objectives of the CU Cancer Center.
Studies in all areas of cancer research - laboratory, clinical, prevention and control, and psychosocial cancer research - will be considered for funding.
ACS IRG Grants aim to entice young faculty to pursue cancer-related research problems and are reserved for applicants who are in their first few years as junior faculty members (instructors and assistant professors) and who are in the process of establishing independent cancer research programs.
Questions regarding the ACS-IRG seed grants and application should be directed to Paige Diller.
All applications should be submitted here. Paper applications will not be accepted or reviewed.
Each award is for 1 year in the amount of $30,000.
Application Due Date: Monday, January 31, 2022
Call for Applications: Clinical Faculty Scholars
Join a longstanding network of successful clinical and outcomes researchers!
We are recruiting early-career researchers for a highly effective training program in mentored research.
The CCTSI Clinical Faculty Scholars Program is looking for 5-6 new scholars for the 2022-2024 cohort.
This program is a two-year intensive mentored junior faculty development program designed to develop research-oriented faculty into independent investigators in patient-oriented clinical, outcomes or policy research.
Participants typically submit grants for major external funding and have gaps in mentorship, key skills, grantsmanship and career planning.
Please see the requirements for sponsorship, including protected research time for the scholar and program fees. Applications can be submitted via the CCTSI website. Questions and inquiries can be sent to Kathleen Spindle.
Call for applications are due March 18, 2022
This bulletin is distributed on the 1st & 3rd Tuesday of the month for the CU Anschutz Research Community.
Past Research Bulletins can be found here.
Please click here if you wish to be added to this distribution.